TY - JOUR
T1 - Identification of a degradation signal at the carboxy terminus of SREBP2
T2 - A new role for this domain in cholesterol homeostasis
AU - Kober, Daniel L.
AU - Xu, Shimeng
AU - Li, Shili
AU - Bajaj, Bilkish
AU - Liang, Guosheng
AU - Rosenbaum, Daniel M.
AU - Radhakrishnan, Arun
N1 - Funding Information:
ACKNOWLEDGMENTS. We thank Mike Brown and Joe Goldstein for their continued encouragement, advice, and critical reading of the manuscript. We also thank Jay Horton, Russell Debose-Boyd, and Jin Ye for many helpful discussions; Yulian Zhou and Gustavo Torres-Ramirez for their assistance during an early phase of this work; Linda Donnelly and Angela Carroll for producing the 2G10 antibody; Karen Chapman, Danya Vazquez, and Daphne Rye for expert technical assistance; and Lisa Beatty, Ijeoma Dukes, Camille Harry, Briana Carter, Elise Morgan, Leticia Esparza, and Shomanike Head for assistance with cell culture. This work was supported by the Welch Foundation (I-1793 to A.R. and I-1770 to D.M.R.), NIH (HL20948 to A.R. and GM116387 to D.M.R.), Fondation Leducq (19CVD04 to A.R.), and the Mallinckrodt Foundation Scholar Award (to D.M.R.). D.L.K. is a recipient of a postdoctoral fellowship from the American Heart Association (18POST34080141).
Funding Information:
17. A. Sundqvist et al., Control of lipid metabolism by phosphorylation-dependent deg-radation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab. 1, 379–391 (2005). Methods Reagents and materials used in this study, buffers and media, antibodies, plasmids, sequence analysis, cell culture, generation of SREBP2-deficient cells, transient transfection of cells, coimmunoprecipitation assays, organelle fractionation, immunoblot analysis, protein overexpression in Sf9 cells, purification of SREBP2-CTD/Scap-CTD complexes, assay to measure interaction between SREBP2-CTD and Scap-CTD, and reproducibility of data are described in detail in SI Appendix, Methods. Data Availability. All study data are included in the article and supporting information. ACKNOWLEDGMENTS. We thank Mike Brown and Joe Goldstein for their continued encouragement, advice, and critical reading of the manuscript. We also thank Jay Horton, Russell Debose-Boyd, and Jin Ye for many helpful discussions; Yulian Zhou and Gustavo Torres-Ramirez for their assistance during an early phase of this work; Linda Donnelly and Angela Carroll for producing the 2G10 antibody; Karen Chapman, Danya Vazquez, and Daphne Rye for expert technical assistance; and Lisa Beatty, Ijeoma Dukes, Camille Harry, Briana Carter, Elise Morgan, Leticia Esparza, and Shomanike Head for assistance with cell culture. This work was supported by the Welch Foundation (I-1793 to A.R. and I-1770 to D.M.R.), NIH (HL20948 to A.R. and GM116387 to D.M.R.), Fondation Leducq (19CVD04 to A.R.), and the Mallinckrodt Foundation Scholar Award (to D.M.R.). D.L.K. is a recipient of a postdoctoral fellowship from the American Heart Association (18POST34080141). 18. E. Nagoshi, Y. Yoneda, Dimerization of sterol regulatory element-binding protein 2 via the helix-loop-helix-leucine zipper domain is a prerequisite for its nuclear locali-zation mediated by importin beta. Mol. Cell. Biol. 21, 2779–2789 (2001). 19. S. J. Lee et al., The structure of importin-beta bound to SREBP-2: Nuclear import of a transcription factor. Science 302, 1571–1575 (2003). 20. J. Sakai et al., Identification of complexes between the COOH-terminal domains of sterol regulatory element-binding proteins (SREBPs) and SREBP cleavage-activating protein. J. Biol. Chem. 272, 20213–20221 (1997). 21. J. Sakai, A. Nohturfft, J. L. Goldstein, M. S. Brown, Cleavage of sterol regulatory element-binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies. J. Biol. Chem. 273, 5785–5793 (1998). 22. X. Gong et al., Structure of the WD40 domain of SCAP from fission yeast reveals the molecular basis for SREBP recognition. Cell Res. 25, 401–411 (2015). 23. X. Gong et al., Complex structure of the fission yeast SREBP-SCAP binding domains reveals an oligomeric organization. Cell Res. 26, 1197–1211 (2016). 24. Y. Ikeda et al., Regulated endoplasmic reticulum-associated degradation of a poly-topic protein: p97 recruits proteasomes to insig-1 before extraction from membranes. J. Biol. Chem. 284, 34889–34900 (2009). 25. X. Wang, R. Sato, M. S. Brown, X. Hua, J. L. Goldstein, SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77, 53–62 (1994). 26. X. Hua, J. Sakai, Y. K. Ho, J. L. Goldstein, M. S. Brown, Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection. J. Biol. Chem. 270, 29422–29427 (1995). 27. O. Schmidt et al., Endosome and Golgi-associated degradation (EGAD) of membrane proteins regulates sphingolipid metabolism. EMBO J. 38, e101433 (2019). 28. D. Xu et al., PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus. Nat. Commun. 6, 8100 (2015). 29. P. Tontonoz, J. B. Kim, R. A. Graves, B. M. Spiegelman, ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13, 4753–4759 (1993). 30. J. D. Horton, J. L. Goldstein, M. S. Brown, SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125–1131 (2002). 31. S. Rong et al., Expression of SREBP-1c requires SREBP-2-mediated generation of a sterol ligand for LXR in livers of mice. eLife 6, e25015 (2017). 32. Y. A. Moon et al., The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab. 15, 240–246 (2012). 33. V. C. Hannah, J. Ou, A. Luong, J. L. Goldstein, M. S. Brown, Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J. Biol. Chem. 276, 4365–4372 (2001). CELL BIOLOGY
Publisher Copyright:
© 2020 National Academy of Sciences. All rights reserved.
PY - 2020/11/10
Y1 - 2020/11/10
N2 - Lipid homeostasis in animal cells is maintained by sterol regulatory element-binding proteins (SREBPs), membrane-bound transcription factors whose proteolytic activation requires the cholesterol-sensing membrane protein Scap. In endoplasmic reticulum (ER) membranes, the carboxyl-terminal domain (CTD) of SREBPs binds to the CTD of Scap. When cholesterol levels are low, Scap escorts SREBPs from the ER to the Golgi, where the actions of two proteases release the amino-terminal domains of SREBPs that travel to the nucleus to up-regulate expression of lipogenic genes. The CTD of SREBP remains bound to Scap but must be eliminated so that Scap can be recycled to bind and transport additional SREBPs. Here, we provide insights into how this occurs by performing a detailed molecular dissection of the CTD of SREBP2, one of three SREBP isoforms expressed in mammals. We identify a degradation signal comprised of seven noncontiguous amino acids encoded in exon 19 that mediates SREBP2’s proteasomal degradation in the absence of Scap. When bound to the CTD of Scap, this signal is masked and SREBP2 is stabilized. Binding to Scap requires an arginine residue in exon 18 of SREBP2. After SREBP2 is cleaved in Golgi, its CTD remains bound to Scap and returns to the ER with Scap where it is eliminated by proteasomal degradation. The Scap-binding motif, but not the degradation signal, is conserved in SREBP1. SREBP1’s stability is determined by a degradation signal in a different region of its CTD. These findings highlight a previously unknown role for the CTD of SREBPs in regulating SREBP activity.
AB - Lipid homeostasis in animal cells is maintained by sterol regulatory element-binding proteins (SREBPs), membrane-bound transcription factors whose proteolytic activation requires the cholesterol-sensing membrane protein Scap. In endoplasmic reticulum (ER) membranes, the carboxyl-terminal domain (CTD) of SREBPs binds to the CTD of Scap. When cholesterol levels are low, Scap escorts SREBPs from the ER to the Golgi, where the actions of two proteases release the amino-terminal domains of SREBPs that travel to the nucleus to up-regulate expression of lipogenic genes. The CTD of SREBP remains bound to Scap but must be eliminated so that Scap can be recycled to bind and transport additional SREBPs. Here, we provide insights into how this occurs by performing a detailed molecular dissection of the CTD of SREBP2, one of three SREBP isoforms expressed in mammals. We identify a degradation signal comprised of seven noncontiguous amino acids encoded in exon 19 that mediates SREBP2’s proteasomal degradation in the absence of Scap. When bound to the CTD of Scap, this signal is masked and SREBP2 is stabilized. Binding to Scap requires an arginine residue in exon 18 of SREBP2. After SREBP2 is cleaved in Golgi, its CTD remains bound to Scap and returns to the ER with Scap where it is eliminated by proteasomal degradation. The Scap-binding motif, but not the degradation signal, is conserved in SREBP1. SREBP1’s stability is determined by a degradation signal in a different region of its CTD. These findings highlight a previously unknown role for the CTD of SREBPs in regulating SREBP activity.
KW - Scap | cholesterol | endoplasmic reticulum | Golgi | proteasome
UR - http://www.scopus.com/inward/record.url?scp=85096079988&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096079988&partnerID=8YFLogxK
U2 - 10.1073/pnas.2018578117
DO - 10.1073/pnas.2018578117
M3 - Article
C2 - 33106423
AN - SCOPUS:85096079988
SN - 0027-8424
VL - 117
SP - 28080
EP - 28091
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 45
ER -